IHS Chemical Week

Regions :: Western Europe

Covidien completes separation of pharmaceuticals business including its API business

1:12 AM MDT | July 2, 2013 | Deepti Ramesh

Healthcare products company Covidien (Dublin) says it has completed the previously announced separation of its pharmaceuticals business, which is now held by Mallinckrodt (Dublin), a new independent company. Covidien announced in December 2011 that it planned to spin-off the pharmaceuticals business, and the spin off includes the company’s active pharmaceutical ingredients (API) business. In the fiscal year ended 28 September 2012, the pharmaceuticals business of Covidien recorded sales of $2 billion, and the API business within that recorded sales of $433...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa